top of page

You can stay up to date with the formal and informal 'goings on' at RAPIvD by following us on LinkedIn and X. 

If it's more formal company news and developments that you're looking for. Bingo, you're here.

  • X
  • LinkedIn

News

Pharmista accepted into BioInnovation Institute program

1 Mar 2024

Pharmista accepted into BioInnovation Institute program

Pharmista, already a participant in the SmiLe life sciences start-up business incubator program has now been accepted to the BioInnovation Institute (BII) Venture Lab program in Copenhagen.

Patent breakthrough for reusable pregnancy test device

19 Oct 2023

Patent breakthrough for reusable pregnancy test device

Pharmista Technologies, has announced that the European Patent Organisation (EPO) has approved their European patent application for "A REUSABLE TEST DEVICE"

RAPIvD develops patented reusable pregnancy device

23 Jun 2023

RAPIvD develops patented reusable pregnancy device

RAPIvD has assisted with the invention of a reusable pregnancy device for Swedish company, Pharmista Technologies

RAPIvD strengthens ties with Stream Bio

7 Feb 2023

RAPIvD strengthens ties with Stream Bio

RAPIvD has signed a partnership agreement with Stream Bio to use their conjugated polymer nanoparticles (CPNs) in lateral flow assay development projects.

Influenza A/B Test Development Enters Optimisation Phase

6 Jan 2023

Influenza A/B Test Development Enters Optimisation Phase

RAPIvD has announced successful prototype tests in developing a rapid multiplexed influenza A/B lateral flow assay.

RAPIvD Achieves ISO 13485 Certification

9 Dec 2022

RAPIvD Achieves ISO 13485 Certification

RAPIvD has achieved certification for
meeting ISO 13485 medical devices standards for ‘contract development and manufacture of lateral
flow assays for IVD’

Gemina Labs buys 19% stake in RAPIvD

8 Dec 2022

Gemina Labs buys 19% stake in RAPIvD

RAPIvD has announced the sale of a 19% stake in the business to the publicly listed Vancouver-based, Gemina Labs.

bottom of page